BioCentury
ARTICLE | Company News

Alkermes and Glaxo finalize agreement

June 27, 2000 7:00 AM UTC

The companies completed a deal announced in February giving Glaxo (GLX; LSE:GLXO) license to ALKS's AIR pulmonary drug delivery technology for use in four respiratory disease indications (see BioCent...